1/1/2018-6/30/2018 |
|
Advertising expenses
|
$0.00
|
1/1/2018-6/30/2018 |
|
Photocopies, scans
|
$0.00
|
1/1/2018-6/30/2018 |
|
Computer equipment, supplies
|
$0.00
|
1/1/2018-6/30/2018 |
|
Professional dues
|
$0.00
|
1/1/2018-6/30/2018 |
|
Fax charges
|
$0.00
|
1/1/2018-6/30/2018 |
|
Internet fees
|
$0.00
|
1/1/2018-6/30/2018 |
|
Legal fees
|
$0.00
|
1/1/2018-6/30/2018 |
|
Postage, shipping, delivery
|
$0.00
|
1/1/2018-6/30/2018 |
|
Office supplies, equipment
|
$0.00
|
1/1/2018-6/30/2018 |
|
Printing expenses
|
$0.00
|
1/1/2018-6/30/2018 |
|
Public relations expenses
|
$0.00
|
1/1/2018-6/30/2018 |
|
Rent
|
$0.00
|
1/1/2018-6/30/2018 |
|
Office and support staff salaries
|
$0.00
|
1/1/2018-6/30/2018 |
|
Professional subscriptions
|
$0.00
|
1/1/2018-6/30/2018 |
|
Taxes
|
$0.00
|
1/1/2018-6/30/2018 |
|
Telephone, cell phone, handheld
|
$0.00
|
1/1/2018-6/30/2018 |
|
Utilities (heat, water, electricity)
|
$0.00
|
1/1/2018-6/30/2018 |
|
Other operating expenses
|
$0.00
|
| | Total operating expenses |
$0.00
|
|
Activities, Bill Numbers and Titles
|
|
Client: Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
Senate Bill
|
2202
|
An Act furthering health empowerment and affordability by leveraging transformative health care.
|
Oppose
|
$4,500.00
|
N/A
|
House Bill
|
1128
|
An Act relative to Diabetes prevention
|
Support
|
$720.00
|
N/A
|
House Bill
|
1171
|
An Act to create a Massachusetts rare disease advisory council
|
Support
|
$1,800.00
|
N/A
|
House Bill
|
2219
|
An Act ensuring community hospital acceleration, revitalization and transformation
|
Neutral
|
$4,500.00
|
N/A
|
| | |
Total amount
|
$11,520.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|